Running title: Carotid-sparing radiotherapy for early glottis cancer
INTRODUCTION
The treatment of early laryngeal glottis (T1/T2N0M0) cancer involves the use of primary radiotherapy (RT), typically using two parallel-opposed lateral radiotherapy beams.
Consequently, the carotid arteries are usually included in the treatment field as collateral structures, exposing them to endothelial injury and subsequent risk of stroke or transient ischaemic attack (1) . Treating the entire larynx allows for an adequate margin (planning target volume (PTV)) to account for movement during swallowing, which can be up to 3.5 cm in the superior-inferior direction (2) . Vocal cord motion during regular breathing (3) should also be accounted for when treatment volumes are significantly reduced.
Recently, carotid-sparing intensity-modulated radiotherapy (IMRT) has generated interest in the hope of avoiding long-term carotid toxicity, as well as concerns relating to geographical misses and long-term normal tissue toxicity (4) . This technique requires the larynx clinical target volume (CTV) and PTV margins to be redefined to address the balance between local control and late normal tissue toxicity. Adequate allowance for laryngeal movement during swallowing and breathing is crucial in determining a PTV that balances vocal cord displacement and sparing the carotid arteries.
The aim of this review was to summarise the current literature on carotid-sparing RT for early glottis cancer, with particular focus on definitions of target volumes and the carotid arteries as organs at risk (OARs), and suggestions for standardization of these structures, dose constraints, and dose reporting.
Materials and methods

Search strategy and selection criteria
We performed a systematic search of Pubmed (1  st January 2000 to 31  st December 2015) for English language articles using the search terms: "carotid", "radiotherapy", "larynx". The abstracts or available data of this search were reviewed to include or exclude references for full text review. Articles reporting on patients treated with IMRT for early glottis cancer or planning studies investigating carotid-sparing IMRT in this population were eligible for inclusion, as were case reports. Studies that did not investigate or report radiation doses to the carotid arteries were excluded from this review.
Relevant references not clearly identifying patient populations or study design were included in the initial review to avoid erroneous exclusion. The full text articles from the selected references were scrutinized to select the final set of articles for review and analysis. The reference lists of these articles were also reviewed, and references from relevant titles were obtained and reviewed according to the above selection criteria.
Data abstraction and analysis
The outcomes of interest were: target volume (gross tumour volume (GTV), CTV, PTV)
definitions, carotid and spinal cord OAR definition, carotid and spinal cord OAR dose constraint and reporting. Field set-up, planning technique and dose prescription were also recorded. Each parameter was considered and reported separately.
Results
The search revealed 73 references (Fig 1) . Of these, 43 were published after 1 st January 2000, and confirmed the concept of carotid-sparing RT is a recent one. Fifteen references met the inclusion criteria from the initial search. Two studies were based on the same patient cohort and reported twice -the reference not related to carotid-sparing RT was excluded in each case (15 -2 = 13) . Full text review of these articles revealed a further three references that met the inclusion criteria. Therefore, a total of 16 references met the inclusion criteria for this review (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) . These included 2 case reports, 11 planning studies, and 3 prospective studies (one published in abstract from only).
Outlining (Table 1) Gross tumour volume (GTV)
The gross tumour volume (GTV) definition varied from none (N = 5) (7, 9, 11, 17, 19 ) to bilateral true vocal cords (5, 8) . This was defined based on endoscopy findings and any diagnostic imaging for some studies (6, 20) . Gomez et al (5) defined the GTV on CT findings only. Some studies did not delineate a GTV (7, 9, 11, 17, 19) . Mourad et al (13) Gy (7, 9, 10, 17) .
Carotid arteries
Some studies contoured both carotid arteries as a single organ at risk (see Table 1 ). Others defined a left and right carotid OAR. The superior and inferior extent of the carotid arteries varied, and often not reported. Only 3 studies (7, 9, 19) applied a 3-5 mm PRV. Carotid artery constraints were applied in only 2 studies: Riegel et al (12) (mean dose as low as possible), and Zumsteg et al (mean dose <52 Gy) (18).
Planning techniques (Table 2) Most studies utilized IMRT with a 3 to 9-field technique. Four studies (10, 12, 19 , 20) used arc therapy. Two studies developed tomotherapy plans to deliver RT (14, 17) . The study by
Matthiesen et al also developed RT plans using proton therapy and utilized 3 uniform scanning beams (19).
Image-guided radiotherapy (IGRT)
Five studies used daily image guidance (6, 8, 14, 16, 20) . The CTVs and PTVs in these studies were smaller than conventional fields and did not include all the cartilaginous structures of the larynx. Chatterjee et al was the only study to maintain the traditional larynx CTV, but did edit the PTV away from the carotid arteries (14) .
Kinematics
Two studies (17, 20) advised patients not to swallow during treatment in order to try and minimize the displacement that occurs during swallowing. Neither study described whether patient compliance during treatment was assessed. Single vocal cord irradiation was investigated in 2 studies (13, 16) , but only one study utilized daily image guidance with cone beam CT (CBCT) (16) .
DISCUSSION
This review highlights a lack of consensus in target volume definitions. As field sizes get smaller with carotid-sparing techniques, it is even more important to ensure the tumour is always encompassed within the treated volume. GTV delineation is, therefore, crucial and endoscopy and diagnostic imaging findings should be incorporated in this process and reported in studies. Four-dimensional CT scanning (3) and magnetic resonance imaging coregistration (21) may improve GTV localization and, perhaps more importantly, quantify vocal cord motion during breathing and allow for adaptation of treatment to account for this.
It is also clear that CTV definition is variable and should be clarified before this technique becomes standard clinical practice and studies begin to report outcome data. Risk of microscopic spread to the cartilaginous structures of the larynx is low in correctly staged early glottis cancers (hence, some of these patients may be adequately treated with laser resection), yet these are often included in the CTV. CTV definitions also appear to have been defined according to laryngeal motion and, strictly speaking, should be reclassified as PTV definitions as they refer to the internal target volume. We believe PTV delineation should be dependent on whether or not centres have access to daily IGRT. We advocate more generous PTV margins that include both vocal cords and other cartilaginous structures of the larynx for those centres without an IGRT programme.
The larynx PTVs in most studies were similar to a standard larynx field except in the posterior direction, where the field is reduced to allow for carotid-sparing. This PTV did not differ dramatically from standard practice and would be relatively easy to introduce into clinical practice. Image-guided radiotherapy and 4-dimensional CT-planning to account for motion during breathing, as well as swallowing, would potentially allow for further reduction in PTV margins (22).
It is important to remember that the time spent swallowing during a patient's treatment has been calculated to be less than 1% (23, 24). One study reported maximum anterior and superior displacements of 6.3 mm and 11. Variability will result in significant differences in mean carotid artery doses and may not be comparable from study to study.
We recommend defining the carotid OAR as the extra-cranial extent of the carotid artery (inferiorly from the aortic arch on the left and brachiocephalic trunk on the right and extended superiorly to at least 2.5 cm superior to the hyoid bone). We believe this carotid OAR is reasonable to calculate realistic mean doses to a defined, reproducible length of carotid artery. The average diameter of the common carotid artery is around 6.1 (SD 0.8) mm for females and 6.5 (SD 1.0) mm in males (25). During the cardiac cycle, the carotid artery luminal diameter can change by up to 15% (26). A 15% increase in 6.5 mm is 0.98 mm, so a further 1 mm margin (before applying the PRV) adequately accounts for carotid diameter changes during the cardiac cycle.
The lack of a carotid OAR dose constraint for most of these studies is a weakness and should be more clearly defined in future prospective studies. The length/volume/diameter of carotid artery does not appear to be important. Rather, the carotid artery behaves as a serial organ and it is the dose of RT to a particular section of artery that is important (1). It would be reasonable to set a stringent constraint of a maximum dose of <35 Gy (27, 28) to demonstrate a positive impact of carotid-sparing RT on future neurological events.
The spinal cord should be contoured (from the foramen magnum superiorly to at least 2.5 cm below the PTV) and a spinal cord PRV created by a 3 -5 mm expansion (depending on institutional policy) in all directions of the spinal cord OAR. It is important to note that reported spinal cord constraints are derived based on standard fractionation (2 Gy per fraction) and some studies used hypofractionated regimens (14, 15) . This becomes important when spinal cord dose constraints are set at 45 Gy for IMRT or arc therapy.
Spinal cord constraints should be stringent and reported when treating patients with IMRT.
Newer radiation techniques such as proton therapy may provide incremental benefits for carotid-sparing (19). The use of MRI for RT planning may further enhance tumour localization and quantification of motion during treatment (29) . These techniques, however, are only useful and comparable with other techniques and studies if accepted definitions of target volume delineation are applied.
There are some limitations to consider. Tumour location may dictate feasibility of carotidsparing, and this technique may only be reasonable for tumours located on the anterior cord.
With 4 dimensional CT planning and IGRT, vocal cord displacement can be more accurately studied in a prospective setting and potentially allow for further reduction in PTV margins.
The use of magnetic resonance imaging in radiotherapy planning may allow for assessment of displacement of vocal cord tumour. These techniques, however, will be restricted to centres with the relevant experience and may not be generally applicable. Therefore, in order to address both carotid-sparing and local control, we would suggest that the technique that makes the greatest allowance for uncertainties in target volume delineation and RT planning would be applicable in most cancer centres that treat these tumours. In the context of a clinical trial, multi-centre participation will be crucial for accrual and generalizability of results.
CONCLUSION
Ultimately, long-term prospective data are required to show the benefit of carotid-sparing.
Lower RT dose to carotid arteries may reduce the incidence of radiation-induced atherosclerosis and subsequent stroke risk. Pooled data will prove useful as most studies will report on small numbers of patients. Therefore, adopting a consensus now on how to define target volumes, dose constraints and dose reporting will be crucial to allow this to occur in future. 
